P
PBH icon

Pitcairn’s Prestige Consumer Healthcare PBH Stock Holding History

Pitcairn’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,306
Closed -$264K – 696
2025
Q2 		$264K Buy
+3,306
New +$277K 0.02% 596
2020
Q1 		– Sell
-12,699
Closed -$514K – 518
2019
Q4 		$514K Sell
12,699
-294
-2% -$11K 0.05% 251
2019
Q3 		$450K Buy
12,993
+757
+6% +$24.9K 0.04% 263
2019
Q2 		$388K Buy
12,236
+608
+5% +$18.1K 0.04% 301
2019
Q1 		$348K Buy
+11,628
New +$333K 0.04% 304
2018
Q4 		– Sell
-6,675
Closed -$253K – 513
2018
Q3 		$253K Sell
6,675
-603
-8% -$22.8K 0.03% 463
2018
Q2 		$279K Buy
+7,278
New +$245K 0.03% 428
2016
Q3 		– Sell
-4,004
Closed -$222K – 516
2016
Q2 		$222K Sell
4,004
-16
-0.4% -$881 0.03% 407
2016
Q1 		$215K Buy
+4,020
New +$198K 0.03% 430

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Pitcairn's PBH Position: Q3 2025 in Review

Pitcairn sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 3,306 shares — an estimated $264K sold.

Pitcairn first reported a position in PBH in Q1 2016 and held it in 9 quarters. The position peaked at $514K in Q4 2019. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Pitcairn reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Pitcairn sold 3,306 Prestige Consumer Healthcare shares in Q3 2025, an estimated $264K.
  • Pitcairn first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 9 quarters.
  • Pitcairn's Prestige Consumer Healthcare position peaked at $514K in Q4 2019.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Pitcairn's 13F filing for Q3 2025, filed 12 Nov 2025.